K S Raju
Overview
Explore the profile of K S Raju including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raju K, Maheshwari R, Sastry P
Lipids
. 2016 Aug;
11(10):741-6.
PMID: 27519480
Total lipid content in the thermophilic fungi-Thermoascus aurantiacus, Humicola lanuginosa, Malbranchea pulchella var.sulfurea, andAbsidia ramosa-varied from 5.3 to 19.1% of mycelial dry weight. The neutral and polar lipid fractions accounted...
2.
Montalto S, Gupta A, Hakmi A, Raju K
J Obstet Gynaecol
. 2011 Feb;
31(2):199-200.
PMID: 21281053
No abstract available.
3.
Herbert A, Anshu , Culora G, Dunsmore H, Gupta S, Holdsworth G, et al.
BJOG
. 2010 Feb;
117(6):736-45.
PMID: 20184570
Objectives: To investigate why invasive cervical cancers developed in a high-risk urban population with an established screening programme and to place cancers in the context of high-grade cervical intraepithelial neoplasia...
4.
Montalto S, Hakmi A, Moth P, Raju K, Coutts M, Papadopoulos A, et al.
Eur J Gynaecol Oncol
. 2009 Mar;
30(1):35-9.
PMID: 19317254
Objective: The purpose of this study was to investigate what proportion of cases showing a well differentiated endometrioid endometrial adenocarcinoma in the hysterectomy specimen removed at two UK cancer centres...
5.
Ahmed A, Dew T, Lawton F, Papadopoulos A, Devaja O, Raju K, et al.
Eur J Gynaecol Oncol
. 2007 May;
28(2):103-8.
PMID: 17479670
Background: Optimal cytoreduction is a major prognostic factor in ovarian cancer; several clinical, radiological and biochemical predictors have been studied. Tumour M2-PK (TU M2-PK) is over-expressed in tumour cells and...
6.
Ahmed A, Dew T, Lawton F, Papadopoulos A, Devaja O, Raju K, et al.
Eur J Gynaecol Oncol
. 2007 May;
28(2):83-8.
PMID: 17479666
Background: Pyruvate kinase isoenzyme M2-PK is instrumental to tumour metabolism and hence over-expressed in tumour cells leading to detectable plasma concentrations. Objectives: To assess the degree of association between M2-PK...
7.
Yazbek J, Raju K, Ben-Nagi J, Holland T, Hillaby K, Jurkovic D
Ultrasound Obstet Gynecol
. 2007 Apr;
29(5):489-95.
PMID: 17444554
Objectives: To assess the value of pattern recognition for the preoperative ultrasound diagnosis of borderline ovarian tumors (BOTs). Methods: This was a prospective study of women who were referred to...
8.
Yazbek J, Aslam N, Tailor A, Hillaby K, Raju K, Jurkovic D
Ultrasound Obstet Gynecol
. 2006 Aug;
28(3):320-4.
PMID: 16881074
Objective: To compare the value of the risk of malignancy index (RMI) and the ovarian crescent sign (OCS) in the diagnosis of ovarian malignancy. Methods: This was a prospective observational...
9.
Hillaby K, Aslam N, Salim R, Lawrence A, Raju K, Jurkovic D
Ultrasound Obstet Gynecol
. 2004 Feb;
23(1):63-7.
PMID: 14971002
Objective: The aim of the study was to evaluate whether the presence of normal ovarian tissue adjacent to an adnexal tumor (the 'ovarian crescent sign') could assist in the preoperative...
10.
Dodds W, Morgan M, Wolfe C, Raju K
Eur J Cancer Care (Engl)
. 2004 Feb;
13(1):82-7.
PMID: 14961779
The 2-week wait rule for cancer referrals became effective in December 2000 for all cancers treated by the National Health Service in the UK. Attainment of this target depends initially...